Superintendent flags $3 million in reductions and $1 million prescription‑drug cost spike in FY27 planning
Loading...
Summary
Superintendent Dr. Johnson told the Wallingford‑Swarthmore board the district is targeting roughly $3 million in spending reductions for FY27 (about $2M from staffing reorganization and $1M from narrowed expenditures) but must absorb March variances including a $1M year‑over‑year increase in prescription drug insurance costs; the administration plans a budget presentation in April.
Superintendent Dr. Johnson told the board on March 23 that the district is on track to present an FY27 budget next month that reflects approximately $3 million in reductions identified through a staffing reorganization and operational savings. He said the reorganization alone is expected to save about $2 million and that further reductions in supplies, professional development and contracted services generated roughly another $1 million in savings, but March updates have eroded about $905,000 of those gains.
Dr. Johnson outlined several March budget variances: the Delaware County Intermediate Unit final special‑education assessment for next year is $639,800 (up from an earlier projection of $465,000), and prescription drug costs for district employee insurance jumped from $2.6 million this year to an expected $3.6 million next year — a $1 million difference the superintendent said will “absorb” much of the district’s projected revenue capacity under Act 1 (which he said yields roughly $2 million in new revenue potential).
He described the district’s approach: Miss Moseley will present the initial FY27 budget to the board in April aligned with board priorities; the administration plans measured steps, continued evaluation of vacancies and attrition, and a focus on efficiency and return on investment while maintaining student outcomes. The superintendent also noted internal corrections related to collective bargaining and paid time‑off assumptions accounted for part of March’s variance.
The administration emphasized there is not an immediate shortfall but warned that continued reliance on fund balance could create future deficits. Dr. Johnson said he will continue to meet with principals and the leadership team about positions under review, and that retirements and an HR director vacancy will be examined for potential savings.
Clarifying details extracted from the meeting: the staffing reorganization is estimated to save about $2,000,000; other spending reductions are estimated at about $1,000,000; March variances reduced net savings by roughly $905,000; prescription drug costs are projected to rise from $2,600,000 to $3,600,000 for FY27; the expected additional revenue capacity through Act 1 was cited as roughly $2,000,000.
